Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / zoetis long term buy despite safety concerns

ZTS - Zoetis: Long-Term Buy Despite Safety Concerns

Zoetis Inc. Class A

2024-05-03 14:37:00 ET

Summary

  • Zoetis is a leader in animal health, focusing on R&D to develop innovative medicines and technologies for pets and livestock.
  • Concerns have arisen about the safety of their drugs, but Zoetis appears confident and reported impressive revenue growth.
  • The stock experienced volatility but has since recovered, and the long-term outlook for Zoetis remains positive.
  • Zoetis' Librela and Solensia franchise has the potential to be a major growth driver, reaching over $1 billion in annual sales.

Investment Thesis

Animal health leader Zoetis ( ZTS ) boasts a strong market position and emphasizes R&D to deliver innovative medicines, vaccines, and technologies for pets and livestock. Recent examples include Librela and Solensia, showcasing their commitment to improving pet lives....

For further details see:

Zoetis: Long-Term Buy Despite Safety Concerns
Stock Information
Company Name: Zoetis Inc. Class A
Stock Symbol: ZTS
Market: NYSE
Menu
ZTS ZTS Quote ZTS Short ZTS News ZTS Articles ZTS Message Board
Get ZTS Alerts

News, Short Squeeze, Breakout and More Instantly...